SCHEMBL9926356

SCHEMBL9926356

CC1CCC[C@H](C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17562404 1.00
SCHEMBL61016 1.00
SCHEMBL60635 1.00
SCHEMBL14446340 1.00
SCHEMBL9926357 1.00
SCHEMBL14621567 0.89 POLB (0.34)
SCHEMBL9062787 0.84
SCHEMBL27888 0.84
SCHEMBL9681629 0.84
SCHEMBL9681638 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170247366-A1 SUBSTITUTED 4-ALKOXYPICOLINAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2017-08-31 US disclosed
US-20170196862-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-07-13 US disclosed
US-20120148502-A1 Carbohydrate-Mediated Tumor Targeting Arizona Board of Regents, a body corporate of the State of Ariz. acting for and on behalf of Ariz. (US) 2012-06-14 US disclosed